1161 - 1170 of 8819 Results
Title
Year
-
RESTRICTEDTitle: Glucose-lowering drugs, cognition, and dementia: The clinical evidenceJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 137Issue #:Start Page: 104654End Page: 104654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104654Best OA location URL: http://manuscript.elsevier.com/S0149763422001439/pdf/S0149763422001439.pdfCitation Count: 8
-
RESTRICTEDTitle: Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?Journal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-022-00317-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-022-00317-xCitation Count: 4
-
RESTRICTEDTitle: Cognitive Syndromes Associated With Movement DisordersJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page: 726End Page: 749Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001134Citation Count: 1
-
RESTRICTEDTitle: Long-term Employment Outcomes After Epilepsy Surgery in ChildhoodJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 20Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011418Best OA location URL: https://n.neurology.org/content/neurology/96/20/969.1.full.pdfCitation Count: 0
-
RESTRICTEDTitle: Tracer development for PET imaging of proteinopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 114-115Issue #:Start Page: 115End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2022.04.001Best OA location URL: https://doi.org/10.1016/j.nucmedbio.2022.04.001Citation Count: 3
-
RESTRICTEDTitle: The Future of Research in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1351End Page: 1351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1717Citation Count: 31
-
RESTRICTEDTitle: Motor subtype in Parkinson's disease: Different disorders or different stages of disease?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 957End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26657Citation Count: 91
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease2018RESTRICTEDTitle: Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 109Issue #:Start Page: 249End Page: 257Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.04.004Citation Count: 514
-
RESTRICTEDTitle: The emerging role of Rab GTPases in the pathogenesis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 196End Page: 207Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27270Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/d21a08f5-cedc-5b9b-84f8-22c5ae15eee6/downloadCitation Count: 51
-
RESTRICTEDTitle: Disease-modifying strategies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 11Start Page: 1442End Page: 1450Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26354Citation Count: 192